Insights Into Prostate Cancer 2022
Perspectives on drivers in treatment decisions in the management of prostate cancer
Select Report
Southwest – March 16, 2022
Faculty Chair
Scott Tagawa, MD, MS, FACP
Weill Cornell Medical Center, New York, NY, USA
More Information
- Virtual series
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment of prostate cancer
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: apalutamide, darolutamide, enzalutamide, androgen deprivation therapy, docetaxel, abiraterone, and combinations of these drugs
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region
